Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


23.07.2018

1 Am J Dermatopathol
1 Clin Cancer Res
1 Clin Exp Metastasis
3 J Am Acad Dermatol
2 J Immunother
1 J Invest Dermatol
3 Melanoma Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. COTA C, Saggini A, Lora V, Kutzner H, et al
    Uncommon Histopathological Variants of Malignant Melanoma: Part 1.
    Am J Dermatopathol. 2018 Jul 17. doi: 10.1097/DAD.0000000000001218.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  2. JOHNSON DB, Bordeaux JM, Kim JY, Vaupel CA, et al
    Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of anti-PD-1 Therapies in Metastatic Melanoma.
    Clin Cancer Res. 2018 Jul 18. pii: 1078-0432.CCR-18-0309.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  3. SWE T, Kim KB
    Update on systemic therapy for advanced cutaneous melanoma and recent development of novel drugs.
    Clin Exp Metastasis. 2018 Jul 17. pii: 10.1007/s10585-018-9913.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  4. WALDMAN RA, Grant-Kels JM
    The Role of Sunscreen in the Prevention of Cutaneous Melanoma and Non-Melanoma Skin Cancer.
    J Am Acad Dermatol. 2018 Jul 13. pii: S0190-9622(18)32276.
    PubMed     Text format    

  5. VON SCHUCKMANN LA, Wilson LF, Hughes MCB, Beesley VL, et al
    Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primary.
    J Am Acad Dermatol. 2018 Jul 12. pii: S0190-9622(18)32232.
    PubMed     Text format     Abstract available

  6. LI Y, Kulkarni M, Trinkaus K, Cornelius LA, et al
    Second Primary Melanomas: Increased Risk and Decreased Time to Presentation in Patients exposed to Tanning Beds.
    J Am Acad Dermatol. 2018 Jul 12. pii: S0190-9622(18)32231.
    PubMed     Text format     Abstract available


    J Immunother

  7. TAJMIR-RIAHI A, Bergmann T, Schmid M, Agaimy A, et al
    Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy.
    J Immunother. 2018;41:35-38.
    PubMed     Text format     Abstract available

  8. SUN Y, Lee SK, Oo TH, Rojas-Hernandez CM, et al
    Management of Immune-mediated Cytopenias in the Era of Cancer Immunotherapy: A Report of 4 Cases.
    J Immunother. 2018;41:32-34.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  9. FORSTHUBER A, Lipp K, Andersen L, Ebersberger S, et al
    CXCL5 as regulator of neutrophil function in cutaneous melanoma.
    J Invest Dermatol. 2018 Jul 13. pii: S0022-202X(18)32353.
    PubMed     Text format     Abstract available


    Melanoma Res

  10. NUNES LF, Quintella Mendes GL, Koifman RJ
    Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA).
    Melanoma Res. 2018 Jul 16. doi: 10.1097/CMR.0000000000000476.
    PubMed     Text format     Abstract available

  11. OLAVERRIA SALAVAGGIONE GN, Duggan MC, Carson WE
    Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.
    Melanoma Res. 2018 Jul 16. doi: 10.1097/CMR.0000000000000474.
    PubMed     Text format     Abstract available

  12. BRUNSSEN A, Jansen L, Eisemann N, Waldmann A, et al
    Long-term relative survival from melanoma in Germany 1997-2013.
    Melanoma Res. 2018 Jul 16. doi: 10.1097/CMR.0000000000000482.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: